Tobacco-funded research is still appearing in highly-cited medical journals - despite attempts by some to cut ties altogether ...

Pharmaceutical manufacturer Sigachi Industries has announced a 10 per cent final dividend for FY25 after posting a strong Q4 ...

South Korean pharmaceutical and biotech companies are on track to exceed 10 trillion won ($7.5 billion) in licensing revenues ...

Two of Ace investor and one of India’s Warren Buffett, Madhusudan Kela’s favourite stocks now trade at discounts of over 50%.

Despite regulation changes in the Chinese healthcare industry, we think CSPC is well-positioned to maintain relatively strong revenue growth. First, generic drugs normally face the most severe price ...

Seven pharmaceutical giants with a presence in New Jersey have announced billions in expansions. The timing is no surprise, health care analysts say.

From mRNA breakthroughs to cloud-based analytics, sector specialists outline the technological innovations and skills ...

We assign Veeva’s commercial solutions a wide moat based on customer switching costs. Veeva CRM is Veeva’s cloud-based customer relationship management platform. It markets to pharmaceutical and ...

Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases ...

Pharma company stocks tumbled after Donald Trump announced a plan to reduce U.S. drug prices, but regained some ground on belief the plan would be hard to implement Drug prices are expected to decline ...

The payments have raised concerns that doctors could be influenced to favour specific drugs or prescribe them over talking ...